Suppr超能文献

卡托普利在治疗难治性心力衰竭最初48小时内疗效的增强。与静脉滴注硝酸甘油的比较

[Enhancement of the effect of captopril in the 1st 48 hours of treating refractory heart failure. A comparison with intravenous trinitrine].

作者信息

Le Pailleur C, Baubion N, Metzger J P, Heulin A, Vacheron A, Di Matteo J

出版信息

Arch Mal Coeur Vaiss. 1984 Jun;77(6):700-6.

PMID:6431936
Abstract

The favourable haemodynamic effects of vasodilator drugs in refractory cardiac failure sometimes alter rapidly after the initial dose. This tachyphylactic phenomenon was looked for during captopril therapy in 14 patients with chronic cardiac failure resistant to digitalo-diuretic therapy and conventional vasodilator drugs. The average age of the patients was 64,4 +/- 3,8 years. Eleven patients had signs of congestive cardiac failure while the remaining three patients had only left ventricular failure. Four patients were classified as Stage III and the other ten Stage IV of the NYHA classification. Right heart catheter studies were performed with a Swan Ganz catheter and systemic pressures were measured by femoral artery catheterisation. Right and left pressures and cardiac output were measured under basal conditions, and 1 and 5 hours after a single dose of captopril (early and late periods). Captopril was given in between meals in 3 to 6 daily doses; in 10 of the 14 cases the dose was 50 mg 6 hourly. The haemodynamic parameters were recorded again during the early and late periods after the dose of captopril 24 and 48 hours after starting therapy. Captopril is a mixed vasodilator and is effective from the first hour of administration. It preferentially lowered pulmonary capillary pressure (PCP) from 29,6 +/- 0,92 mmHg to 21,4 +/- 1,04 mmHg (delta PCP: -27,7%, p less than 0,01). Mean systemic blood pressure (MBP) fell less from 92,4 +/- 3,51 mmHg to 76,6 +/- 3,4 mmHg (delta MBP: -17%, p less than 0,01).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

血管扩张剂药物对难治性心力衰竭有良好的血流动力学效应,但有时在初始剂量后会迅速改变。在14例对洋地黄 - 利尿剂疗法和传统血管扩张剂药物耐药的慢性心力衰竭患者中,于卡托普利治疗期间研究了这种快速耐受性现象。患者的平均年龄为64.4±3.8岁。11例患者有充血性心力衰竭体征,其余3例仅有左心室衰竭。4例患者被归类为纽约心脏协会(NYHA)分级的III级,其他10例为IV级。使用Swan Ganz导管进行右心导管检查,并通过股动脉插管测量体循环压力。在基础状态下以及单次服用卡托普利后1小时和5小时(早期和晚期)测量右心和左心压力以及心输出量。卡托普利在餐间给药,每日3至6次;14例中的10例剂量为每6小时50毫克。在开始治疗后24小时和48小时,在卡托普利给药后的早期和晚期再次记录血流动力学参数。卡托普利是一种混合血管扩张剂,给药后1小时即有效。它优先将肺毛细血管压(PCP)从29.6±0.92 mmHg降至21.4±1.04 mmHg(PCP变化量:-27.7%,p<0.01)。平均体循环血压(MBP)从92.4±3.51 mmHg降至76.6±3.4 mmHg,下降较少(MBP变化量:-17%,p<0.01)。(摘要截选至250字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验